ELRIG are busily preparing for the 8th Annual Drug Discovery conference which will be held at Manchester Convention Centre on 2nd & 3rd September 2014. The programme contain presentations from leading scientists across Europe and beyond, covering exciting advances in basic and translational aspects of drug discovery and brings together Academia, Biotech, Vendors and Pharma into a single community.
Aptamer Group are delighted to be invited back to the Innovation Zone (stand IZ12) for the second year running, where we will be exhibiting our new and exciting technologies. We have over 20 years combined expertise in the development of nucleic acid aptamers to peptides, proteins, cells, tissue samples, micro-organisms and small molecules.
Dr David Bunka, CTO, world leading high-throughput aptamer selection expert will be addressing the Target Validation audience on 3 September at 12.00 in Charter 1. Dr Bunka will be discussing how our technology enables us to greatly speed up the identification of novel biomarkers as well as diagnostics/therapeutic candidate molecules.
If you would like to find out more information about Aptamer group of companies in advance please contact us on (0) 8447 707038 or email email@example.com